>ABOUT TAKEDA >Our Management

Our Management

( As of April 1, 2015 )

Board members

Representative Director
Chairman of the Board 

Yasuchika Hasegawa

Representative Director President & CEO

Christophe Weber

Senior Managing Director
Senior Vice President,
Corporate Strategy Officer, Corporate Strategy Department
President, Takeda Pharmaceuticals International, Inc. (not continuous presence)

Shinji Honda

Managing Director
Special Missions

Yasuhiko Yamanaka

Chief Medical & Scientific Officer
Executive Vice President of Takeda Pharmaceuticals International, Inc.

Tadataka Yamada, M.D.

President, Japan Pharma Business Unit

Masato Iwasaki, Ph.D.

Senior Vice President,
Chief Financial Officer

Francois Roger

Outside Director
Honorary Advisor, JFE Holdings, Inc.

Fumio Sudo

Outside Director
Chairman of the Board,
Mitsubishi Corporation

Yorihiko Kojima

Outside Director
Komatsu Ltd.

Masahiro Sakane

Corporate Auditors

Corporate Auditor

Naohisa Takeda

Corporate Auditor

Teruo Sakurada

Corporate Auditor

Tsuguoki Fujinuma

Corporate Auditor

Shiro Kuniya

Corporate Officers

Haruhiko Hirate

Corporate Communications & Public Affairs Officer,

Global Head of Public Affairs 

Marc Princen

President, EUCAN Business Unit

Tadao Hirouchi

Head of East Japan Sales, Japan Pharma Business Unit

David Osborne

Global Human Resources Officer

Tetsuyuki Maruyama, Ph.D.

General Manager, Pharmaceutical Research Division

Yoshihiro Nakagawa

Global General Counsel

Christophe Bianchi

President, Global Oncology Business Unit

Rajeev Venkayya

President, Global Vaccine Business Unit

Giles Platford

President, Emerging Markets Business Unit

Thomas Wozniewski

Global Manufacturing and Supply Officer

Gerard Greco

Global Quality Officer

Mwana Lugogo

Global Compliance Officer

Andrew Plump, M.D., Ph.D.

Chief Medical & Scientific Officer Designate